My mother has a grade IV GBM. 1st removed 8/2010, chemo pills, radiation etc....reoccurrence 11/2011, 2nd removal 12/2011, went right into an Intra-Arterial (IA) Avastin clinical trial procedure Jan 6th (which infuses it right into the brain via a catheter so its 50% more dosage then IV) and then one Intravenous (IV) treatment of the same drug on Feb 8th. MRI on Feb 14th showed that the tumor was back and the size of an orange already, so the Avastin did not work on her tumor. Her surgeon Dr John Boockvar at Weill Cornell was surprised by this. The good news was, that the doctor had sent her 2nd tumor to a special lab (Caris Life Sciences) and tested the tissues against different drugs. She has a highly targeted protein EGFR (epidermal growth factor receptor) which is located on the surface of certain cells that responded to a particular "inhibitor", the drug Erlotinib (generic), brand name is Tarceva. Today mom started the Tarceva clinical trial with a 28 day cycle of 1 pill a day (150 mg ). The drug is commonly used for lung cancer and pancreatic cancer so it’s not covered for GBM….the trial provides the meds for free however.
Here is a summary of the Tarceva trialhttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT
Here is the actual trial on the .gov website http://clinicaltrials.gov/ct2/show/NCT00301418?term=tarceva+for+GBM&rank=3
Good luck!